Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia
Daniela Pucciarelli(Medical University of Vienna), Christine Häfner(Medical University of Vienna)
Cited by 16